Climb Bio Cash Flow Statement (2020-2026) | CLYM

Cash Flow Statement Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income (Quarter)
-51.11M-21.40M-29.11M-17.49M-12.65M-14.49M-24.98M-7.84M-5.06M-24.63M-2.74M-57.67M-9.88M-8.64M-21.27M-8.54M-14.46M-29.20M-46.05M-92.40M
Share-based Compensation (Quarter)
1.24M1.15M1.54M1.77M1.78M0.31M0.78M0.66M1.20M0.47M0.51M2.92M1.66M2.02M1.01M10.20M7.84M1.60M19.50M
Cash from Operations (Quarter)
-12.97M-7.88M-10.78M-13.97M-4.17M-8.45M-15.18M-7.96M3.49M-0.95M-1.82M-0.67M-7.55M-5.52M-15.43M-11.15M-12.14M-15.63M-14.38M-10.55M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)
-0.08M-0.29M-0.19M-0.10M0.07M0.40M0.49M0.74M0.75M0.35M0.06M0.17M0.53M0.67M0.57M0.52M0.51M0.30M0.39M
Depreciation & Amortization (CF) (Quarter)
0.04M0.03M0.03M0.04M0.03M
Change in Working Capital
Change in Account Payables (Quarter)
0.42M-0.97M-0.56M0.23M0.41M-0.74M0.11M0.01M-0.14M-0.67M0.02M-1.18M-0.22M0.41M0.07M0.09M-0.39M1.79M-1.41M0.20M
Change in Accured Expenses (Quarter)
-0.62M1.41M0.97M0.50M-1.66M0.61M-1.46M-1.33M-0.49M0.67M-0.74M1.07M0.10M1.02M2.04M-1.09M-0.79M0.22M-1.53M0.94M
Other Working Capital Changes (Quarter)
-0.09M-0.14M-0.12M-0.09M-0.11M-0.10M-0.12M-0.11M-0.12M0.10M-0.27M-0.04M-0.06M0.06M-0.21M-0.06M0.07M
Investing Activities
Capital Expenditures (Quarter)
-0.01M0.21M0.01M0.07M1.44M-0.30M
Change in Acquisitions & Divestments (Quarter)
21.55M24.61M55.25M20.99M23.25M36.93M30.50M36.75M13.75M7.00M16.00M25.48M39.08M30.53M31.90M25.60M
Cash from Investing Activities (Quarter)
-106.92M-8.05M-4.04M15.69M8.51M14.28M5.80M-1.60M28.04M36.75M13.75M-9.64M-71.79M-53.41M-42.75M4.79M15.26M25.54M-12.96M-57.26M
Financing Activities
Other financing activities (Quarter)
119.75M108.81M0.01M103.36M
Change in Capital Stock
Shares Issued (Quarter)
2.74M2.92M4.23M4.53M4.49M5.99M4.05M4.37M4.89M4.59M4.26M1.55M0.97M2.82M5.56M5.66M6.43M8.48M8.47M
Net Equity Issued and Repurchased (Quarter)
93.83M-93.79M0.00M0.02M0.53M0.29M0.01M41.87M2.27M0.04M
Misc.
Cash from Financing Activities (Quarter)
83.14M0.04M0.00M0.02M0.53M0.29M0.01M128.40M2.27M0.04M-0.02M0.01M103.70M
Exchange Rate Effect (Quarter)
0.08M-0.18M-1.05M-0.99M1.81M0.23M0.40M0.00M-0.33M-0.03M0.02M0.11M-0.06M-0.02M0.02M
Change in Cash (Quarter)
-36.66M-15.90M-14.99M0.67M3.34M7.64M-9.15M-9.14M32.06M35.76M11.92M118.11M-76.97M-58.95M-58.21M-6.34M3.12M9.88M-27.33M35.89M
Free Cash Flow (Quarter)
-12.97M-7.88M-10.78M-13.97M-4.17M-8.45M-15.18M-7.96M3.49M-0.95M-1.82M-0.67M-7.54M-5.74M-15.44M-11.21M-13.58M-15.63M-14.38M-10.24M
Net Cash Flow (Quarter)
-36.74M-15.90M-14.81M1.72M4.33M5.83M-9.38M-9.54M32.05M36.09M11.95M118.09M-77.07M-58.89M-58.19M-6.36M3.12M9.88M-27.33M35.89M